help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pantel, J.
Right arrow Articles by Bidart, J.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pantel, J.
Right arrow Articles by Bidart, J.-M.
Endocrinology Vol. 139, No. 2 527-533
Copyright © 1998 by The Endocrine Society


ARTICLES

Characterization of Human Lutropin Carboxyl- Terminus Isoforms1

Jacques Pantel, Philippe Robert, Frederic Troalen, Michelle Kujas, Dominique Bellet and Jean-Michel Bidart

Département de Biologie Clinique, Institut Gustave-Roussy (J.P., P.R., F.T., D.B., J.-M.B.), 94805 Villejuif, France; Laboratoire d’Immunologie CNRS URA 1484, Faculté des Sciences Pharmaceutiques et Biologiques (D.B., J.-M.B.), 75006 Paris, France; and Service d’Histologie-Embryologie-Cytogénétique, CNRS URA2115, CHU Pitié-Salpétrière (M.K.), 75013 Paris, France

Address all correspondence and requests for reprints to: Pr. J. M. Bidart, Département de Biologie Clinique, Institut Gustave-Roussy, rue Camille Desmoulins, 94805 Villejuif, France. E-mail: bidart{at}igr.fr

Human lutropin (hLH) exhibits both carbohydrate and peptidic heterogeneities that affect its biological potency and the duration of its activity in vivo. Peptidic changes within the hLH ß-subunit are characterized as intrachain proteolytic nicking and carboxyl terminus heterogeneity. To date, the carboxyl terminus of hLHß appears to end at either position Gln114 or Gly117, as determined by sequencing of purified subunit. Furthermore, the complementary DNA for hLHß predicts a protein containing an additional peptidic stretch, which would make the ß-subunit 121 residues long. This extension may be responsible for the particular intracellular behavior of hLHß. To investigate the carboxyl terminus polymorphism of natural hLHß, monoclonal antipeptide antibodies were raised against a synthetic peptide mimicking the 104–119 portion of hLHß. One antibody, designated LHP09, was found to specifically react with the recombinant hLHß ending at position hLHß[Leu119] but not with other recombinant forms ending at [Ser116], [Phe120] or [Leu121]. Immunochemical analysis of hLH, either pituitary or urinary in origin, indicated that only pituitary hLH contains a Leu119-ending form of hLHß. Finally, immunohistochemical detection was performed using LHP09 and showed specific staining of a normal adult pituitary gland. These observations support the in vivo existence of intrapituitary molecular forms of hLHß ending at various positions between Gln114 and Leu121.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. Jablonka-Shariff, C. A. Pearl, A. Comstock, and I. Boime
A Carboxyl-terminal Sequence in the Lutropin {beta} Subunit Contributes to the Sorting of Lutropin to the Regulated Pathway
J. Biol. Chem., April 25, 2008; 283(17): 11485 - 11492.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society